Genetic factors as potential molecular markers of human oocyte and embryo quality

J Assist Reprod Genet. 2021 May;38(5):993-1002. doi: 10.1007/s10815-021-02196-z. Epub 2021 Apr 24.

Abstract

Successful human reproduction requires gamete maturation, fertilization, and early embryonic development. Human oocyte maturation includes nuclear and cytoplasmic maturation, and abnormalities in the process will lead to infertility and recurrent failure of IVF/ICSI attempts. In addition, the quality of oocytes/embryos in the clinic can only be determined by morphological markers, and there is currently a lack of molecular markers for determining oocyte quality. As the number of patients undergoing IVF/ICSI has increased, many patients have been identified with recurrent IVF/ICSI failure. However, the genetic basis behind this phenotype remains largely unknown. In recent years, a few mutant genes have been identified by us and others, which provide potential molecular markers for determining the quality of oocytes/embryos. In this review, we outline the genetic determinants of abnormalities in the processes of oocyte maturation, fertilization, and early embryonic development. Currently, 16 genes (PATL2, TUBB8, TRIP13, ZP1, ZP2, ZP3, PANX1, TLE6, WEE2, CDC20, BTG4, PADI6, NLRP2, NLRP5, KHDC3L, and REC114) have been reported to be the causes of oocyte maturation arrest, fertilization failure, embryonic arrest, and preimplantation embryonic lethality. These abnormalities mainly have Mendelian inheritance patterns, including both dominant inheritance and recessive inheritance, although in some cases de novo mutations have also appeared. In this review, we will introduce the effects of each gene in the specific processes of human early reproduction and will summarize all known variants in these genes and their corresponding phenotypes. Variants in some genes have specific effects on certain steps in the early human reproductive processes, while other variants result in a spectrum of phenotypes. These variants and genetic markers will lay the foundation for individualized genetic counseling and potential treatments for patients and will be the target for precision treatments in reproductive medicine.

Keywords: Embryonic development; Fertilization; Gene mutations; Human oocyte maturation.

Publication types

  • Review

MeSH terms

  • Biomarkers / blood*
  • Embryonic Development / genetics
  • Female
  • Humans
  • Mutation / genetics
  • Oocytes / growth & development
  • Oocytes / metabolism*
  • Oogenesis / genetics
  • Phenotype
  • Proteins / classification
  • Proteins / genetics*
  • Reproductive Techniques, Assisted*

Substances

  • Biomarkers
  • Proteins